Combined Neural and Behavioral Therapies to Enhance Stroke Recovery
Combining Neural and Behavioral Therapies to Enhance Stroke Recovery
1 other identifier
interventional
22
1 country
1
Brief Summary
Stroke is the leading cause of long-term disability in this country with more than 1 million Americans reporting difficulty with daily activities. Loss of independence in self-care tasks is primarily due to limited recovery of the arm. This study will determine if the addition of Transcranial Magnetic Stimulation (TMS) to excite the lesioned hemisphere (side of the brain affected by the stroke), to progressive functional task exercise either of the weakened arm alone or of both arms together will improve arm recovery to a greater degree than one of these two types of arm exercise alone. Individuals post-stroke will participate in 16 sessions of 1) arm rehabilitation alone (with the weaker arm only or with both arms together) or 2) arm rehabilitation plus TMS. The investigators will assess arm movement ability and function immediately following the 4-week intervention and at a 30-day follow-up to determine retention of immediate gains. The investigators hypothesize that those who receive TMS as an adjuvant will have improved arm movement ability than those who only exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Feb 2013
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2009
CompletedFirst Posted
Study publicly available on registry
June 29, 2009
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2015
CompletedResults Posted
Study results publicly available
July 5, 2017
CompletedAugust 21, 2017
July 1, 2017
2.7 years
June 25, 2009
November 21, 2016
July 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wolf Motor Function Test Change
Change, in seconds, between Pre-intervention and post-intervention (4 wks following pre-intervention). The time to complete 15 separate upper extremity functional tasks are recorded. These 15 separate timed events are averaged to provide one time, in seconds. This is considered an Activity Measure on the WHO ICF model.
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
Secondary Outcomes (4)
Upper Extremity Fugl-Meyer Motor Assessment Change
Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
Grip Strength Change
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
Motor Activity Log - Amount of Use Change
Change Between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
Motor Activity Log - How Well Change
Change between Pre-intervention (baseline) to Post-intervention (4 wks following pre-intervention)
Study Arms (2)
Real rTMS
EXPERIMENTALReal rTMS + unimanual paretic UE training
Sham rTMS
ACTIVE COMPARATORSham rTMS + unimanual paretic UE training
Interventions
UE exercise for 4 hours (two hours 1:1 with therapist and two hours independent at home) for 16 sessions (4 sessions/week for 4 weeks)
Eligibility Criteria
You may qualify if:
- Diagnosis of 1st stroke \> 6 months
- Sub-cortical stroke confirmed with CT or MRI
- Passive range of motion in bilateral shoulder and elbow within functional limits
- UE Fugl-Meyer shoulder/elbow subcomponent score between 15 - 25
- years of age
You may not qualify if:
- Use of medications that may lower seizure threshold
- History of epilepsy, brain tumor, learning disorder, mental retardation, drug or alcohol abuse, dementia, major head trauma, or major psychiatric illness
- evidence of epileptiform activity on EEG obtained before beginning treatment
- history or radiographic evidence of arteriovenous malformation, intracortical hemorrhage, subarachnoid hemorrhage, or bilateral cerebrovascular disease,
- history of cortical stroke
- history of implanted pacemaker or medication pump, metal plate in skull, or metal objects in the eye or skull
- pregnancy
- pain in either upper extremity that would interfere with movement
- unable to understand 3-step directions
- orthopedic condition in back or UE or impaired corrected vision that would alter kinematics of reaching
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida, 32608, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Dorian Rose, Research Health Scientist
- Organization
- Malcom Randall VAMC
Study Officials
- PRINCIPAL INVESTIGATOR
Dorian Kay Rose, PhD MS BS
North Florida/South Georgia Veterans Health System, Gainesville, FL
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2009
First Posted
June 29, 2009
Study Start
February 1, 2013
Primary Completion
September 30, 2015
Study Completion
September 30, 2015
Last Updated
August 21, 2017
Results First Posted
July 5, 2017
Record last verified: 2017-07